Treating Venous Thromboembolism with JETi™ Thrombectomy System

Clinical Outcomes For Acute Venous Thrombosis Treatment

Percutaneous thrombectomy with the JETi™ Peripheral Thrombectomy System for the treatment of venous thrombosis

Overview: Retrospective Study

Cournoyer-Rodrigue et al., JVIR. 2019.

Mechanical and pharmacomechanical based thrombectomy may improve clinical outcomes, reduce concomitant CDT and lessen need for intensive care unit stays compared to anticoagulation alone.

To evaluate the safety and efficacy of JETi™ Thrombectomy System in treating acute venous thrombosis.

Retrospective evaluation of 18 consecutive patients with 21 instances of acute venous thrombosis in JETi™ Thrombectomy System new user facility.

Primary Endpoints
Technical Success Rate (restoration of antegrade flow with or without additional treatment of an underlying obstructive lesion) and Procedural Success Rate (technical success with or without the addition of overnight CDT).

Clinical Outcomes

The JETi™ Peripheral Thrombectomy System achieved a 100% procedural success rate in 18 consecutive patients with a wide variety of target treatment vessels and had ZERO reports of blood transfusions, hypotension or hemolysis..


 Procedural Success RateSingle-Session Clot ReductionOverall Clot Reduction
(Single-Session + Overnight CDT)
Iliofemoral Vein (n=9)100%81%96%
Axillosubclavian Vein (n=10)100%100%100%
Portal Vein (n=2)100%100%100%


*5 patients required overnight CDT.

JETi™ system achieved a 100% procedural success rate in a wide variety of target treatment vessels at a brand-new JETi™ user facility.


JETi™ system can achieve successful venous thrombectomy without overnight catheter directed thrombolysis in most patients.


Reducing the need for overnight thrombolytics can lessen utilization of hospital resources and decrease intensive care unit stays resulting in lower costs compared with CDT.

Lower cost


Cournoyer-Rodrigue et al., JVIR. 2019.

MAT-2209359 v1.0